KRAEMATON INVESTMENT ADVISORS, INC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
KRAEMATON INVESTMENT ADVISORS, INC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$252,726
+17.2%
7,915
+43.5%
0.28%
+18.8%
Q4 2022$215,692
-18.0%
5,5150.0%0.23%
-31.0%
Q3 2022$263,000
+23.5%
5,5150.0%0.34%
+37.2%
Q2 2022$213,000
-32.6%
5,5150.0%0.25%
-17.9%
Q1 2022$316,000
-26.9%
5,515
+1.8%
0.30%
-22.2%
Q4 2021$432,0005,4150.39%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders